FDA has upgraded Fresenius Kabi’s voluntary recall of certain Ivenix Large Volume Pump (LVP) primary administration sets to Class I after the company identified a manufacturing defect that could cause uncontrolled medication flow.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,